News & Updates

Show Multimedia Only
Low-dose polypill: Another step forward in hypertension management? Low-dose polypill: Another step forward in hypertension management?

Low-dose polypill: Another step forward in hypertension management?

12 Dec 2022 byRoshini Claire Anthony

A polypill comprising ultra-low doses of four antihypertensive drugs shows promise in reducing blood pressure (BP) levels compared with standard monotherapy, according to a small study presented at AHA 2022.

12 Dec 2022
Edaravone confers neuroprotection in stroke patients

Edaravone confers neuroprotection in stroke patients

10 Dec 2022

Edaravone appears to be safe and effective in the treatment of patients with ischaemic stroke, yielding improvements in activities of daily living and neurologic deficits in the short term, a study has found.

10 Dec 2022
Erenumab works well in chronic migraine patients across Asia

Erenumab works well in chronic migraine patients across Asia

06 Dec 2022 byJairia Dela Cruz

Erenumab proves to be effective at lowering the number of monthly migraine days in Asian patients with chronic migraine while having a favourable safety profile, according to the results of DRAGON study.

06 Dec 2022
Lecanemab moderately slows decline in early AD, associated with AEs

Lecanemab moderately slows decline in early AD, associated with AEs

06 Dec 2022 byNatalia Reoutova

Lecanemab reduces brain amyloid burden and offers moderate slowing of cognitive decline in early Alzheimer’s disease (AD), but is associated with adverse events (AEs), according to the results of the phase III, double-blind, placebo-controlled CLARITY AD trial, presented at the 15th Clinical Trials on Alzheimer’s Disease (CTAD 2022) conference.

06 Dec 2022